Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has signed a laboratory services agreement to provide its molecular thyroid tests to researchers at Einstein Medical Center of Philadelphia.

Under the terms of the deal, Einstein's endocrinologists and otolaryngologists will have access to Interpace's ThyGenX oncogene panel and ThyraMir microRNA gene expression classifier, which are used to diagnose thyroid nodules with indeterminate cytology. 

Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.